Vaccine Development

Next-generation vaccines for infectious disease prevention and therapeutic applications

Vaccine Innovation Platform

Oracle BioTech develops cutting-edge vaccines using mRNA technology, viral vectors, and protein-based platforms to address emerging infectious diseases and provide therapeutic vaccination solutions.

Vaccine Sciences

mRNA Vaccine Platform

Rapid-response mRNA vaccine technology for pandemic preparedness and personalized medicine applications.

  • Pandemic preparedness vaccines
  • Personalized cancer vaccines
  • Respiratory disease prevention
  • Next-generation adjuvants
Learn More
Vaccine Manufacturing

Viral Vector Vaccines

Adenoviral and other viral vector platforms for robust immune responses against infectious diseases.

  • Adenoviral vectors
  • Lentiviral platforms
  • Prime-boost strategies
  • Mucosal immunity targeting
Learn More
Vaccine Laboratory

Protein-Based Vaccines

Recombinant protein vaccines with novel adjuvant systems for enhanced immunogenicity and safety.

  • Recombinant protein antigens
  • Virus-like particles (VLPs)
  • Nanoparticle vaccines
  • Combination vaccines
Learn More

Vaccine Development Pipeline

Discovery

6 Programs

Antigen discovery and vaccine platform optimization.

Preclinical

4 Programs

Immunogenicity and safety studies in animal models.

Phase I

3 Programs

First-in-human safety and immunogenicity studies.

Phase II

2 Programs

Efficacy studies in target populations.

Phase III

1 Program

Large-scale efficacy trial for respiratory syncytial virus vaccine.

Vaccine Manufacturing Capabilities

GMP Manufacturing

GMP Manufacturing

Full-scale vaccine production facilities with flexible manufacturing capabilities for various vaccine platforms.

Quality Assurance

Quality Assurance

Comprehensive analytical testing and quality control systems ensuring vaccine safety, purity, and potency.